Researchers in Boston found that CGRP-blocking drugs commonly used for migraine may help with endometriosis pain and lesion size. Molly O'Brien has the details in this Migraine Minute news update recognizing Endometriosis Awareness Month.

Read More: https://bit.ly/4jp0cG2

AMD Comorbidities Library: https://bit.ly/3CIrLtd

Cluster Headache Awareness Day is March 21st. In this Migraine Minute News Update Molly O'Brien explains findings from a study that found cluster headache, fibromyalgia, and migraine are frequently comorbid conditions.

Learn More: https://bit.ly/42pSNQS

According to a study published in Neurology, when compared to placebo, this gepant led to significantly greater ability to function normally and a greater reduction in activity limitation when taken during the prodrome phase of an attack.

Molly O'Brien has the details in this Migraine Minute News Update.

Read More: https://bit.ly/3BY2J9d

Kids age 8+ now have access to a non-drug migraine treatment option. In this Migraine Minute News Update, Molly O'Brien explains the FDA clearance of Theranica's Nerivio device for acute and preventive migraine treatment in kids. Read more: https://bit.ly/4fRXRk5

Researchers have identified elevated levels of the gene MERTK, (which is linked to cluster headaches) and its ligand Gal-3, in the nerve tissues of rats and in blood samples of people with cluster headache.

In this Migraine Minute News Update Molly O'Brien breaks down what it means for people living with Cluster.

Read More: https://bit.ly/3ZXzTQ0

Contrary to previous research, a study published in Neurology finds among women, there is no link between migraine and the risk of developing Parkinson's disease. Molly O'Brien explains in this Migraine Minute News Update.

Want to know more about Migraine and Parkinson's disease? Check out this article in AMD's Comorbidities library: https://bit.ly/3XZSaJB

A small study published in the New England Journal of Medicine finds a single IV infusion of a Monoclonal Antibody targeting PACAP reduced monthly migraine days better than placebo.

In this Migraine Minute News Update Molly O'Brien explains.

Read More: https://bit.ly/3XXXNrR

The National Institute of Neurological Disorders and Stroke awards a $2.4 million grant to researchers at the University of Texas Health to examine the link between the circadian clock and severe headache disorders. Molly O'Brien has details in this Migraine Minute News Update.

Read more: bit.ly/3BsNwfT

A study finds treatment with anti-CGRP mAbs does not significantly affect blood pressure or increase the occurrence of hypertension (compared to general population trends) in people 60+. In this Migraine Minute, Molly O'Brien explains the findings.

Read More: bit.ly/3zpcYSB

A study found that anti-CGRP monoclonal antibodies not only reduced absenteeism & presenteeism in Spain, they were found to be cost-effective too.

Read more: http://bit.ly/3S1KS5Y

Image courtesy: DOI 10.1186/s10194-024-01727-0